These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 28475434)

  • 41. [Prognosticating relapse risk based on multiparameter flow cytometric assessment of minimal residual disease in patients with acute myeloid leukemia].
    Wan SG; Zhao H; Sun XJ; He JJ; Su L; Xu J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Jun; 17(3):557-62. PubMed ID: 19549363
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Relevance of presenting white blood cell count and kinetics of molecular remission in the prognosis of acute myeloid leukemia with CBFbeta/MYH11 rearrangement.
    Martín G; Barragán E; Bolufer P; Chillón C; García-Sanz R; Gómez T; Brunet S; González M; Sanz MA
    Haematologica; 2000 Jul; 85(7):699-703. PubMed ID: 10897121
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Minimal/Measurable Residual Disease Detection in Acute Leukemias by Multiparameter Flow Cytometry.
    Fuda F; Chen W
    Curr Hematol Malig Rep; 2018 Dec; 13(6):455-466. PubMed ID: 30446941
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Significance of quantification of WT1 mRNA for monitoring minimal residual disease in acute myeloid leukemia patients].
    Qin YZ; Ruan GR; Li JL; Fu JY; Chang Y; Wang H; Li LD; Liu YR; Chen SS
    Zhonghua Xue Ye Xue Za Zhi; 2005 Nov; 26(11):649-52. PubMed ID: 16620548
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Clinical significance of MRD in AML].
    Ishikawa Y
    Rinsho Ketsueki; 2020; 61(9):1150-1159. PubMed ID: 33162510
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Minimal residual disease monitoring in childhood B lymphoblastic leukemia with t(12;21)(p13;q22); ETV6-RUNX1: concordant results using quantitation of fusion transcript and flow cytometry.
    Alm SJ; Engvall C; Asp J; Palmqvist L; Abrahamsson J; Fogelstrand L
    Int J Lab Hematol; 2017 Apr; 39(2):121-128. PubMed ID: 28004528
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Measurable residual disease study through three different methods can anticipate relapse and guide pre-emptive therapy in childhood acute myeloid leukemia.
    Ramos Elbal E; Fuster JL; Campillo JA; Galera AM; Cortés MB; Llinares ME; Jiménez I; Plaza M; Banaclocha HM; Galián JA; Blanquer Blanquer M; Martínez Sánchez MV; Muro M; Minguela A
    Clin Transl Oncol; 2023 May; 25(5):1446-1454. PubMed ID: 36598635
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MRD in AML: it is time to change the definition of remission.
    Ossenkoppele GJ; Schuurhuis GJ
    Best Pract Res Clin Haematol; 2014; 27(3-4):265-71. PubMed ID: 25455276
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assessment of minimal residual disease in acute myeloid leukemia.
    Grimwade D; Vyas P; Freeman S
    Curr Opin Oncol; 2010 Nov; 22(6):656-63. PubMed ID: 20805746
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Detection of minimal residual disease in acute myelogenous leukemia.
    Raanani P; Ben-Bassat I
    Acta Haematol; 2004; 112(1-2):40-54. PubMed ID: 15179004
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Strikingly different molecular relapse kinetics in NPM1c, PML-RARA, RUNX1-RUNX1T1, and CBFB-MYH11 acute myeloid leukemias.
    Ommen HB; Schnittger S; Jovanovic JV; Ommen IB; Hasle H; Østergaard M; Grimwade D; Hokland P
    Blood; 2010 Jan; 115(2):198-205. PubMed ID: 19901261
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The significance of minimal residual disease in patients with t(15;17).
    Grimwade D
    Best Pract Res Clin Haematol; 2002 Mar; 15(1):137-58. PubMed ID: 11987921
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Detection of Minimal Residual Disease in Acute Myeloid Leukemia by Multi-color Flow Cytometry].
    He C; Zhang QT; Tang P; Sun H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Apr; 30(2):341-345. PubMed ID: 35395960
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Measurement of Residual Disease in Acute Myeloid Leukemia.
    Vedula RS; Lindsley RC
    Curr Hematol Malig Rep; 2017 Dec; 12(6):574-581. PubMed ID: 29064024
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Detection of aml-1/eto fusion gene in patients with acute myeloid leukemia by real-time quantitative RT-PCR].
    Jiang YM; Yuan H; Liu XY; Wang B; Li SJ; Wang N
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):17-22. PubMed ID: 19236739
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development of a NanoString assay to detect leukemogenic fusion transcripts in acute myeloid leukemia.
    Hu D; Zhou W; Wang F; Shu SM; Fan LL; He J; Wang P; He YL; Du W; Zhang JH; Duan JX; Sun L; Zheng J; Li XQ; Li HY; Feng XL; Huang SA
    Int J Lab Hematol; 2016 Dec; 38(6):663-673. PubMed ID: 27460049
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Minimal residual disease in acute myeloid leukemia--current status and future perspectives.
    Kayser S; Walter RB; Stock W; Schlenk RF
    Curr Hematol Malig Rep; 2015 Jun; 10(2):132-44. PubMed ID: 25994952
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic value of minimal residual disease quantification by real-time reverse transcriptase polymerase chain reaction in patients with core binding factor leukemias.
    Krauter J; Gorlich K; Ottmann O; Lubbert M; Dohner H; Heit W; Kanz L; Ganser A; Heil G
    J Clin Oncol; 2003 Dec; 21(23):4413-22. PubMed ID: 14645432
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Prospective study on comparing two methods: for dynamic monitoring of minimal residual disease in acute promyelocytic leukemia].
    Zhang Y; Tian LP; Zhang Y; Duan MH; Qin XM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Feb; 22(1):50-3. PubMed ID: 24598650
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of multiparameter flow cytometry for disease monitoring in AML.
    Kern W; Bacher U; Haferlach C; Schnittger S; Haferlach T
    Best Pract Res Clin Haematol; 2010 Sep; 23(3):379-90. PubMed ID: 21112037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.